Here, the reduction in SFRP1 correlates with activated Wnt-signalling [33, 44] while ectopic overexpression of SFRP1 in breast cancer cells blocks Wnt-signalling, decreasing the migratory potential [45] and inhibiting anchorage-independent growth [37]. The gene discussed is SFRP1; the disease is breast carcinoma.